Laboratoire ObvieLine

Laboratoire ObvieLine is a French medical device company specializing in the development and manufacture of hyaluronic acid-based dermal fillers. Founded in 2005 and headquartered in Dardilly, France, the company is the creator of the Perfectha brand, a comprehensive range of biphasic hyaluronic acid gels. These products are utilized globally for aesthetic procedures including wrinkle correction, facial contouring, and volume restoration. The company's proprietary E-brid technology allows for the production of highly cross-linked gels that offer long-lasting results and high safety profiles. In 2014, Laboratoire ObvieLine was acquired by Sinclair Pharma, and it now serves as a primary manufacturing and R&D hub for the group's global injectable portfolio.